Investigational oral drug combo shows promise for newly diagnosed multiple myeloma

(Mayo Clinic) The investigational drug ixazomib taken orally in combination with lenalidomide and dexamethasone shows promise in patients with newly diagnosed multiple myeloma, according to the results of a phase 1/2 study published in the journal Lancet Oncology.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news